Optomed Plc Stock Exchange Release 26 May 2021 at 13.30, Helsinki
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding
change in holdings
Optomed Plc (“Optomed” or the “Company”) has received a notification in
accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act
(as amended, the “SMA”) from Robert Bosch Venture Capital GmbH (“RBVC”).
According to the notification, the total holdings in Optomed shares and votes
held by RBVC has decreased to below 5.00 % per cent of all of the registered
shares in Optomed on 25 May 2021.
The total number of the Company’s registered shares amounts to 14,003,144
shares. Each share entitles to one vote.
The total position of RBVC subject to the notification:
% of % of shares and voting rights Total of
shares and through financial instruments (total both in %
voting of B) (A+B)
rights
(total
of A)
Resulting 3.45 % - 3.45 %
situation on the
date on
which threshold
was crossed or
reached
Position of 7.90 % - 7.90 %
previous
notification
(if applicable)
Notified details of the resulting situation on the date on which the threshold
was crossed or reached:
A: Shares and voting rights
Class/type of Number % of shares and voting rights
sharesISIN of
code shares
and
voting
rights
Direct Indirect Direct Indirect
(SMA 9:5) (SMA 9:6 (SMA 9:5) (SMA 9:6 ja 9:7)
ja 9:7)
FI4000410881 482,473 - 3.45 % -
SUBTOTAL A 482,473 3.45 %
Information in relation to the person subject to the notification obligation as
contained in the notification
The complete chain of controlled undertakings through which the shares, voting
rights and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity:
Name % of % of shares Total of both
shares and voting
and rights
voting through
rights financial
instruments
Robert Bosch 100 % - 100 % of Robert
Sechste Bosch Venture
Vermögensverwal Capital GmbH
-tungsgesellschaft
mbH
Robert Bosch GmbH 100 % - 100 % of Robert
Bosch Sechste
Vermögens
-verwaltungs
-gesell
-schaftmbH
Robert Bosch 93.99 % - 93.99 % of shares
Stiftung GmbH of of Robert Bosch
(charitable) shares, GmbH
no voting
rights
Robert Bosch 93.17 % 93.17 % of voting
Industrietreuhand of voting rights and 0.01%
KG rights, of shares of
(performs the 0.01% of Robert Bosch GmbH
entrepreneurial shares
ownership
functions)
Further enquiries
Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com, +358(0)50 562
4077.
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld screening devices fundus
cameras with software and artificial intelligence with the aim to transform the
diagnostic process of blinding eye-diseases such as rapidly increasing diabetic
retinopathy. In its business Optomed focuses on eye-screening devices and
software solutions related R&D in Finland and sales through different channels
in over 60 countries. The company has an extensive portfolio of 56 international
patents protecting the technology.